CN117202919A - 用于抑制病原生物体的组合物和方法 - Google Patents

用于抑制病原生物体的组合物和方法 Download PDF

Info

Publication number
CN117202919A
CN117202919A CN202280029052.4A CN202280029052A CN117202919A CN 117202919 A CN117202919 A CN 117202919A CN 202280029052 A CN202280029052 A CN 202280029052A CN 117202919 A CN117202919 A CN 117202919A
Authority
CN
China
Prior art keywords
clostridium
bacteroides
composition
faecalis
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280029052.4A
Other languages
English (en)
Chinese (zh)
Inventor
B·奥勒
S·卡巴莱罗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vedanta Biosciences Inc
Original Assignee
Vedanta Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vedanta Biosciences Inc filed Critical Vedanta Biosciences Inc
Publication of CN117202919A publication Critical patent/CN117202919A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN202280029052.4A 2021-02-18 2022-02-18 用于抑制病原生物体的组合物和方法 Pending CN117202919A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163151003P 2021-02-18 2021-02-18
US63/151,003 2021-02-18
PCT/US2022/017043 WO2022178292A1 (en) 2021-02-18 2022-02-18 Compositions and methods for suppressing pathogenic organisms

Publications (1)

Publication Number Publication Date
CN117202919A true CN117202919A (zh) 2023-12-08

Family

ID=80685400

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280029052.4A Pending CN117202919A (zh) 2021-02-18 2022-02-18 用于抑制病原生物体的组合物和方法

Country Status (5)

Country Link
US (1) US20240316119A1 (https=)
EP (1) EP4294413A1 (https=)
JP (1) JP2024507827A (https=)
CN (1) CN117202919A (https=)
WO (1) WO2022178292A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118580989A (zh) * 2024-03-07 2024-09-03 江南大学 一种能在非水溶性膳食纤维上形成多菌生物膜的混菌组合及多菌生物膜制备方法
CN120531768A (zh) * 2024-09-13 2025-08-26 南方医科大学南方医院 粪副拟杆菌在制备治疗移植物抗宿主病药物中的应用

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7846613B2 (ja) * 2019-08-09 2026-04-15 ヴェダンタ バイオサイエンシーズ インコーポレーテッド 病原菌を抑制するための組成物及び方法
WO2024160742A1 (en) * 2023-01-30 2024-08-08 Mrm Health N.V. Microbial compositions for treating joint inflammation
EP4438051A1 (en) * 2023-03-28 2024-10-02 Biome Inc. Microbiome-based composition for preventing and treating multidrug resistant bacterial infections

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3261761A (en) 1962-05-07 1966-07-19 Arthur W Anderson Method of freeze drying bacterial cultures
US4205132A (en) 1978-07-17 1980-05-27 Microlife Technics, Inc. Lyophilization of bacteria
CS239559B1 (sk) 1983-04-07 1986-01-16 Jozef Rusko Elektrostatická nanášacia kabina
US6368586B1 (en) 1996-01-26 2002-04-09 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
WO2012098358A1 (en) 2011-01-20 2012-07-26 Biopharma Technology Ltd Freeze drying method
WO2014029578A1 (en) 2012-08-24 2014-02-27 Haldor Topsøe A/S Method and catalyzed filter element with improved alkali-resistance for flue gas cleaning
US10973861B2 (en) * 2013-02-04 2021-04-13 Seres Therapeutics, Inc. Compositions and methods
AU2015244700B2 (en) 2014-04-10 2020-08-27 Riken Compositions and methods for induction of Th17 cells
JP2018519295A (ja) 2015-06-22 2018-07-19 プレジデント アンド フェローズ オブ ハーバード カレッジ 粘膜固有層調節性ｔ細胞の誘導
CA3226196A1 (en) * 2016-06-14 2017-12-21 Vedanta Biosciences, Inc. Treatment of clostridium difficile infection
EP3706767A4 (en) 2017-11-09 2021-12-15 Vedanta Biosciences, Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT OF AN ALLERGY
EP3723776A4 (en) 2017-12-11 2022-07-27 Vedanta Biosciences, Inc. Compositions and methods for suppressing pathogenic organisms
EP3999084A4 (en) * 2019-07-19 2023-07-12 Finch Therapeutics Holdings LLC METHODS AND PRODUCTS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118580989A (zh) * 2024-03-07 2024-09-03 江南大学 一种能在非水溶性膳食纤维上形成多菌生物膜的混菌组合及多菌生物膜制备方法
CN120531768A (zh) * 2024-09-13 2025-08-26 南方医科大学南方医院 粪副拟杆菌在制备治疗移植物抗宿主病药物中的应用

Also Published As

Publication number Publication date
EP4294413A1 (en) 2023-12-27
WO2022178292A1 (en) 2022-08-25
US20240316119A1 (en) 2024-09-26
WO2022178292A9 (en) 2023-06-29
JP2024507827A (ja) 2024-02-21

Similar Documents

Publication Publication Date Title
US20250009811A1 (en) Compositions and methods for suppressing pathogenic organisms
AU2017285211B2 (en) Treatment of clostridium difficile infection
CN117202919A (zh) 用于抑制病原生物体的组合物和方法
US11701396B2 (en) Treatment of Clostridium difficile infection
JP7846613B2 (ja) 病原菌を抑制するための組成物及び方法
KR20200136365A (ko) 공동선택 미생물총을 포함하는 조성물 및 그 이용 방법
CN103827291A (zh) 抑制/减少大肠杆菌不同生物型和梭菌属不同生物型的生长的乳酸菌和/或双歧杆菌菌株
US8021883B2 (en) Antibiotic-sensitive lactic acid bacteria strains
HK40114606A (en) Compositions and methods for suppressing pathogenic organisms
HK40104391A (en) Treatment of clostridium difficile infection
Mohamed Use of Bifidobacterium for Treatment and Protective from Entamoeba Histolytica Infection in Mice
HK40007703A (en) Treatment of clostridium difficile infection
HK40007703B (en) Treatment of clostridium difficile infection

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination